Mouse models of diabetic nephropathy
- PMID: 15563560
- DOI: 10.1681/ASN.2004080648
Mouse models of diabetic nephropathy
Abstract
Mice provide an experimental model of unparalleled flexibility for studying mammalian diseases. Inbred strains of mice exhibit substantial differences in their susceptibility to the renal complications of diabetes. Much remains to be established regarding the course of diabetic nephropathy (DN) in mice as well as defining those strains and/or mutants that are most susceptible to renal injury from diabetes. Through the use of the unique genetic reagents available in mice (including knockouts and transgenics), the validation of a mouse model reproducing human DN should significantly facilitate the understanding of the underlying genetic mechanisms that contribute to the development of DN. Establishment of an authentic mouse model of DN will undoubtedly facilitate testing of translational diagnostic and therapeutic interventions in mice before testing in humans.
Similar articles
-
Is the Hp 2-2 diabetic mouse model a good model to study diabetic nephropathy?Diabetes Res Clin Pract. 2013 Jun;100(3):289-97. doi: 10.1016/j.diabres.2013.02.004. Epub 2013 Mar 13. Diabetes Res Clin Pract. 2013. PMID: 23490597 Review.
-
Diabetic nephropathy: of mice and men.Adv Chronic Kidney Dis. 2005 Apr;12(2):128-45. doi: 10.1053/j.ackd.2005.01.004. Adv Chronic Kidney Dis. 2005. PMID: 15822049 Review.
-
A sensitized screen of N-ethyl-N-nitrosourea-mutagenized mice identifies dominant mutants predisposed to diabetic nephropathy.J Am Soc Nephrol. 2007 Jan;18(1):103-12. doi: 10.1681/ASN.2006020164. Epub 2006 Dec 6. J Am Soc Nephrol. 2007. PMID: 17151334
-
Diabetic nephropathy--are there differences between type I and type II?Miner Electrolyte Metab. 1990;16(1):69-72. Miner Electrolyte Metab. 1990. PMID: 2182996 Review.
-
Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.Pediatr Endocrinol Rev. 2008 Aug;5 Suppl 4:958-63. Pediatr Endocrinol Rev. 2008. PMID: 18806710 Review.
Cited by
-
miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes.Diabetologia. 2013 Mar;56(3):663-74. doi: 10.1007/s00125-012-2804-x. Epub 2013 Jan 5. Diabetologia. 2013. PMID: 23292313
-
Paternal multigenerational exposure to an obesogenic diet drives epigenetic predisposition to metabolic diseases in mice.Elife. 2021 Mar 30;10:e61736. doi: 10.7554/eLife.61736. Elife. 2021. PMID: 33783350 Free PMC article.
-
Ablation of the N-type calcium channel ameliorates diabetic nephropathy with improved glycemic control and reduced blood pressure.Sci Rep. 2016 Jun 7;6:27192. doi: 10.1038/srep27192. Sci Rep. 2016. PMID: 27273361 Free PMC article.
-
MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets.Ann N Y Acad Sci. 2015 Sep;1353(1):72-88. doi: 10.1111/nyas.12758. Epub 2015 Apr 15. Ann N Y Acad Sci. 2015. PMID: 25877817 Free PMC article. Review.
-
In Vivo Inhibition of TRPC6 by SH045 Attenuates Renal Fibrosis in a New Zealand Obese (NZO) Mouse Model of Metabolic Syndrome.Int J Mol Sci. 2022 Jun 20;23(12):6870. doi: 10.3390/ijms23126870. Int J Mol Sci. 2022. PMID: 35743312 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical